Ginsenoside Rb3 attenuates oxidative stress and preserves endothelial function in renal arteries from hypertensive rats

British Journal of Pharmacology

Volumn 171, Issue 13, 2014, Pages 3171-3181

  Wang, Youhua ^a   Dong, Jinghui ^b   Liu, Ping ^a   Lau, Chi Wai ^b   Gao, Zhen ^b   Zhou, Duan ^a   Tang, Jingyi ^a   Ng, Chi Fai ^b   Huang, Yu ^b  

^a LONGHUA HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

endothelial dysfunction; ginsenoside Rb3; hypertension; oxidative stress; renal artery

Indexed keywords

ANTIOXIDANT; GINSENOSIDE; GINSENOSIDE RB 3; LOSARTAN; NITRIC OXIDE; PROTEIN P67; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; UNCLASSIFIED DRUG; ANGIOTENSIN II; GINSENOSIDE RB3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; AGED; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOSYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENDOTHELIAL DYSFUNCTION; EX VIVO STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL ARTERY; SMOOTH MUSCLE CONTRACTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASODILATATION; ANIMAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; MIDDLE AGED; PANAX; PATHOPHYSIOLOGY; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; WISTAR KYOTO RAT;

ADULT; AGED; ANGIOTENSIN II; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GINSENOSIDES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERTENSION; MIDDLE AGED; NADPH OXIDASE; NITRIC OXIDE; OXIDATIVE STRESS; PANAX; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES; RENAL ARTERY; VASOCONSTRICTION;

EID: 84902145696     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12660     Document Type: Article

References (24)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et-al (2013). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. British Journal of Pharmacology, 170: 1797-1867.
2. Bu QT, Zhang WY, Chen QC, Zhang CZ, Gong XJ, Liu WC, et al. (2012). Anti-diabetic effect of ginsenoside Rb(3) in alloxan-induced diabetic mice. Med Chem 8: 934-941.
3. Chen X, (1996). Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol 23: 728-732.
4. Dong J, Wong SL, Lau CW, Lee HK, Ng CF, Zhang L, et al. (2012). Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress. Eur Heart J 33: 2980-2990.
5. Fang F, Chen X, Huang T, Lue LF, Luddy JS, Yan SS, (2012). Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model. Biochim Biophys Acta 1822: 286-292.
6. Félétou M, Huang Y, Vanhoutte PM, (2011). Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 164: 894-912.
7. Kilkenny, Browne, Cuthill, Emerson, Altman; 2010), Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
8. Koh KK, Oh PC, Quon MJ, (2009). Does reversal of oxidative stress and inflammation provide vascular protection? Cardiovasc Res 81: 649-659.
9. Lee JG, Lee YY, Wu B, Kim SY, Lee YJ, Yun-Choi HS, et al. (2010). Inhibitory activity of ginsenosides isolated from processed ginseng on platelet aggregation. Pharmazie 65: 520-522.
10. Leung KW, Leung FP, Huang Y, Mak NK, Wong RN, (2007). Non-genomic effects of ginsenoside-Re in endothelial cells via glucocorticoid receptor. FEBS Lett 581: 2423-2428.
11. Leung KW, Leung FP, Mak NK, Tombran-Tink J, Huang Y, Wong RNS, (2009). Protopanaxadiol and protopanaxatriol bind to glucocorticoid and oestrogen receptors in endothelial cells. Br J Pharmacol 156: 626-637.
12. 2-induced senescence in human umbilical endothelial cells: involvement of eNOS pathway. J Cardiovasc Pharmacol 59: 222-230.
13. McGrath J, Drummond G, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
14. Pan C, Huo Y, An X, Singh G, Chen M, Yang Z, et al. (2012). Panax notoginseng and its components decreased hypertension via stimulation of endothelial-dependent vessel dilatation. Vascul Pharmacol 56: 150-158.
15. Shi Y, Han B, Yu X, Qu S, Sui D, (2011). Ginsenoside Rb3 ameliorates myocardial ischemia-reperfusion injury in rats. Pharm Biol 49: 900-906.
16. 2α impairs endothelial function in renovascular hypertensive rats. Antioxid Redox Signal 16: 363-373.
17. Wang T, Yu X, Qu S, Xu H, Han B, Sui D, (2010a). Effect of ginsenoside Rb3 on myocardial injury and heart function impairment induced by isoproterenol in rats. Eur J Pharmacol 636: 121-125.
18. Wang T, Yu XF, Qu SC, Xu HL, Sui DY, (2010b). Ginsenoside Rb3 inhibits angiotensin II-induced vascular smooth muscle cells proliferation. Basic Clin Pharmacol Toxicol 107: 685-689.
19. Wong WT, Tian XY, Chen YC, Leung FP, Liu LM, Lee HK, et al. (2010a). Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension. Circ Res 107: 984-U995.
20. Wong WT, Wong SL, Tian XY, Huang Y, (2010b). Endothelial dysfunction: the common consequence in diabetes and hypertension. J Cardiovasc Pharmacol 55: 300-307.
21. Wong WT, Tian XY, Xu A, Yu J, Lau CW, Hoo RL, et al. (2011). Adiponectin is required for PPARγ-mediated improvement of endothelial function in diabetic mice. Cell Metab 14: 104-115.
22. Ye R, Kong X, Yang Q, Zhang Y, Han J, Zhao G, (2011). Ginsenoside Rd attenuates redox imbalance and improves stroke outcome after focal cerebral ischemia in aged mice. Neuropharmacology 61: 815-824.
23. Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C, (2005). Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg 41: 861-868.
24. Zhu J, Jiang Y, Wu L, Lu T, Xu G, Liu X, (2012). Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia. Neuroscience 202: 342-351.